This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Aktiengesellschaft. Active years: 2003-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
8 out of 721 
2 out of 12,268 
Years Active: 2003-2015
Title: Biography of Inventor Felix Oehme
Introduction
Felix Oehme is a prominent inventor based in Wuppertal, Germany, known for his significant contributions to the field of medicinal chemistry. With a total of 10 patents to his name, he has focused on developing innovative treatments for cardiovascular and hematological diseases.
Latest Patents
Among his latest patents, Felix Oehme has developed novel substituted dihydropyrazolone derivatives aimed at treating cardiovascular and hematological diseases. These compounds are designed for the preparation of medicaments that not only address these diseases but also promote wound healing. Another notable patent involves 4-(pyridin-3-yl)-2(pyridin-2-yl)-1,2-dihydro-3H-pyrazol-3-one derivatives, which serve as specific inhibitors for HIF-pyrolyl-4-hydroxylase, further contributing to the treatment of cardiovascular and hematological conditions.
Career Highlights
Felix Oehme has had a distinguished career, working with Bayer Intellectual Property GmbH and Bayer Aktiengesellschaft. His work at these leading pharmaceutical companies has allowed him to advance his research and develop groundbreaking medicinal compounds.
Collaborations
Throughout his career, Felix has collaborated with notable professionals in the field, including Ingo Flamme and Jens-Kerim Ergüden. These collaborations have enriched his research
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile